San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...
Starting Jan. 1, 2026, Pennsylvania will limit GLP‑1 weight‑loss drugs under Medicaid — threatening access for thousands of ...
The Trump administration has approved six additional states for bans that would prevent people from using food stamps to buy ...
Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...